Compare PALI & APAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PALI | APAD |
|---|---|---|
| Founded | 1996 | 2022 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.2M | 274.8M |
| IPO Year | 2019 | N/A |
| Metric | PALI | APAD |
|---|---|---|
| Price | $1.90 | $10.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 89.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $60.17 |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $9.88 |
| 52 Week High | $2.64 | $10.21 |
| Indicator | PALI | APAD |
|---|---|---|
| Relative Strength Index (RSI) | 57.27 | 65.17 |
| Support Level | $1.57 | $10.01 |
| Resistance Level | $1.93 | $10.21 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 86.79 | 100.00 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
A Paradise Acquisition Corp is a blank check company.